April 23, 2018 / 5:38 AM / 3 months ago

BRIEF-Sensorion’s Sens-401 Reduces Hearing Loss In Preclinical Study

April 23 (Reuters) - SENSORION SA:

* SENSORION’S SENS-401 REDUCES HEARING LOSS IN PRECLINICAL STUDY WHEN ORAL ADMINISTRATION INITIATED UP TO FOUR DAYS AFTER ACOUSTIC TRAUMA

* KEY FINDING IS THAT SENS-401 WAS EFFECTIVE EVEN WHEN TIME BETWEEN ACOUSTIC TRAUMA AND TREATMENT INITIATION REACHED UP TO FOUR DAYS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below